Pharmaceutical

Study shows autistic people are more likely to engage i...

“When we are raised to believe we are broken and defective ... is it any wonder ...

Study mapping how SARS-CoV-2 disrupts mitochondria sugg...

The SARS-CoV-2 virus hijacks our cellular power plants known as mitochondria. A ...

Nonprofit naloxone maker celebrates FDA approval by don...

Naloxone is viewed as a critical way of fighting the opioid epidemic. But its hi...

Meet the scientists trying to stop the next global pand...

“Everybody in the world should be a sentinel, a sentinel not only for his own im...

STAT+: Pharmalittle: Wegovy heart study has docs seeing...

A new study of Wegovy is expected to have a big impact on how clinicians approac...

Opinion: Public pharma is the best solution to the ongo...

Most of the solutions being discussed for drug shortages are just Band-Aids on a...

Opinion: STAT+: One way to create resilient drug supply...

The key to the standardized implementation of this innovation lies in providing ...

‘Underwhelming’: NIH trials fail to test meaningful lon...

The NIH says it’s used up most of its $1.15 billion of long Covid funding and mo...

Amid backlash, Novo Nordisk reports positive cardiovasc...

Wegovy has been approved in the US and Europe for weight loss management in pati...

Jacobio Pharma receives breakthrough therapy designatio...

Jacobio Pharma received breakthrough therapy designation (BTD) for glecirasib to...

Danam signs merger agreement with Artemis

Danam Health has signed a merger deal with publicly traded special purpose acqui...

Artificial intelligence is set to power the future of h...

An increasing amount of information make artificial intelligence (AI) stand out ...

Ginkgo Bioworks and Merck partner to bolster biologic m...

Ginkgo Bioworks has entered into a new partnership with Merck (MSD) to bolster b...

FDA accepts review of Viatris and Mapi’s NDA filing for...

The US Food and Drug Administration (FDA) has accepted for review Viatris and Ma...

Navigating market access in Sweden

Pricing and reimbursement of pharmaceuticals is changing in Sweden, with prices ...

Astellas invests $50m in Poseida’s CAR-T cell therapy

As part of the agreement, Astellas will have exclusive negotiation and first ref...